Bal Pharma Limited Share Price & Technical Analysis
BALPHARMA · ₹88.56 (+7.96%)
Healthcare / Drug Manufacturers - Specialty & Generic
₹88.56
+7.96%
Bal Pharma Limited, together with its subsidiaries, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk drugs. It also provides anti-infectives, pain management, respiratory care, and women's health products under the Azi…
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
18% return in May, 5% avg return in past 3 year May month.
28% return in 2026, -5% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -7% | 7% | -16% | 27% | 18% | – | – | – | – | – | – | – | 28% |
| 25 | -5% | -20% | -6% | 19% | -5% | 5% | -3% | -11% | -6% | -1% | -8% | -5% | -46% |
| 24 | 23% | -14% | -17% | 7% | 16% | -2% | 3% | 20% | -4% | -11% | -3% | 0% | 18% |
| 23 | -9% | -18% | -4% | 21% | 4% | 5% | 8% | -2% | -1% | -9% | 25% | -7% | 14% |
| 22 | 17% | -11% | -5% | 7% | -11% | -4% | 0% | -4% | -2% | -2% | -4% | 4% | -14% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Emerging · Strong
Bal Pharma Limited, together with its subsidiaries, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk drugs. It also provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions, such as prostate enlargement, renal calculi, male infertility, and women health, etc. under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursulin brands; anti-hypertensive, anti-lipidemic, and anti-obese products; skin care and bone health products; herbal liver protective and antioxidant; and cardiac care products under the Secremet and Servace brands. In addition, the company offers a range of APIs for therapeutic areas, such as anti-histamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, and acne treatment, etc.; and various formulations, including tablets, capsules, syrups, suspensions, ophthalmic, creams, and ointments. Further, it engages in the treatment of gastrointestinal disorders; and piles, fistula, and constipation. The company exports its products to approximately 30 countries. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹1.29B
P/E ratio
15.97
52W high
₹111.2
52W low
₹60.00
Volume
65,510
Beta
0.40
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,260
Frequently asked questions
- What is Bal Pharma Limited share price today?
- Bal Pharma Limited (BALPHARMA) last traded around ₹88.56 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does BALPHARMA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for BALPHARMA. Download the app for real-time alerts.
- How can I analyze Bal Pharma Limited stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.